While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...

At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Both Europe and America should rethink their approach. After the work by DeepSeek, China’s hotshot model-maker, Europe has ...

Breyanzi already carries multiple oncology approvals in Europe, including in relapsed ... Thalassemia is a rare, inherited blood disorder with limited treatment options. The disease is hallmarked ...

Biogen Inc. (NASDAQ:BIIB), currently valued at $19.15 billion by market capitalization, reported its earnings for the fourth ...

Action Summit in Paris, Commission President Ursula von der Leyen launched InvestAI. This initiative aims to mobilise €200 ...

Achieving a digital transition that strengthens Europe's strategic competitiveness means addressing the persistent challenges in innovation, adoption, and technological dependency.

L&T Finance Ltd., incorporated in the year 2008, is a Large Cap company (having a market cap of Rs 35,161.71 Crore) operating in NBFC sector. L&T Finance Ltd. key Products/Revenue Segments include ...